| Literature DB >> 32450146 |
Tomonori Kimura1, Atsushi Hesaka2, Yoshitaka Isaka3.
Abstract
d-Serine, a long-term undetected enantiomer of serine, is now showing its potential as a biomarker for kidney diseases. The intra-body dynamics of d-serine, currently defined by blood levels and urinary excretion dynamics, are useful for a comprehensive assessment of kidney function and disease activity. Thus, widespread adoption of d-serine as a biomarker can resolve the long-standing clinical challenge of the early detection and prognostic prediction of kidney diseases. Accuracy and reliability of the measurements are particularly important because these measurements will affect treatment decisions and thus impact the patient's emotional state and quality of life. Accordingly, this review focuses on current clinical challenges in kidney diseases and the potential for monitoring of d-serine to overcome these issues, and discuss the requirements of accurate quantification.Entities:
Keywords: Acute kidney injury; Biomarker; Chronic kidney disease; Glomerular filtration rate; Intra-body dynamics; Urinary excretion; d-Serine
Year: 2020 PMID: 32450146 DOI: 10.1016/j.bbapap.2020.140449
Source DB: PubMed Journal: Biochim Biophys Acta Proteins Proteom ISSN: 1570-9639 Impact factor: 3.036